These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3534307)

  • 1. Immunology of pyelonephritis. VIII. E. coli causes granulocytic aggregation and renal ischemia.
    Kaack MB; Dowling KJ; Patterson GM; Roberts JA
    J Urol; 1986 Nov; 136(5):1117-22. PubMed ID: 3534307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunology of pyelonephritis in the primate model. VI. Effect of complement depletion.
    Roberts JA; Roth JK; Domingue G; Lewis RW; Kaack B; Baskin G
    J Urol; 1983 Jan; 129(1):193-6. PubMed ID: 6338249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology of pyelonephritis. VII. Effect of allopurinol.
    Roberts JA; Kaack MB; Fussell EN; Baskin G
    J Urol; 1986 Oct; 136(4):960-3. PubMed ID: 3531555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of pyelonephritis in the primate model. V. Effect of superoxide dismutase.
    Roberts JA; Roth JK; Domingue G; Lewis RW; Kaack B; Baskin G
    J Urol; 1982 Dec; 128(6):1394-400. PubMed ID: 6759691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of cobra venom factor, an inhibitor of the complement system, on the sequence of morphological events in the rat kidney in experimental pyelonephritis.
    Sullivan MJ; Harvey RA; Shimamura T
    Yale J Biol Med; 1977; 50(3):267-73. PubMed ID: 329591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Events leading to septic death from experimental acute pyelonephritis in the monkey.
    Roberts JA; Kaack MB; Baskin G; Martin LN
    J Urol; 1993 Sep; 150(3):1030-3. PubMed ID: 8345580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicoureteral reflux and pyelonephritis in the monkey: a review.
    Roberts JA
    J Urol; 1992 Nov; 148(5 Pt 2):1721-5. PubMed ID: 1433597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-mediated immune mechanisms in renal infection. II. Effect of decomplementation.
    Miller TE; Phillips S; Simpson IJ
    Clin Exp Immunol; 1978 Jul; 33(1):115-21. PubMed ID: 361314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
    Roberts JA; Kaack MB; Baskin G; Chapman MR; Hunstad DA; Pinkner JS; Hultgren SJ
    J Urol; 2004 Apr; 171(4):1682-5. PubMed ID: 15017266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against retrograde pyelonephritis. I. Production of an experimental model of severe ascending Escherichia coli pyelonephritis without bacteremia in rats.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):345-58. PubMed ID: 4590645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of experimental pyelonephritis in the monkey.
    Roberts JA; Kaack MB; Baskin G
    J Urol; 1990 Jan; 143(1):150-4. PubMed ID: 2403597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of antibody response to acute pyelonephritis by treatment with antibiotics.
    Neal DE; Kaack MB; Baskin G; Roberts JA
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2340-4. PubMed ID: 1804007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemiluminescence response of phagocytes in E. coli induced experimental ascending pyelonephritis.
    Gupta A; Kaur A; Majumdar S; Sharma BK; Ganguly NK
    Biochem Int; 1992 Feb; 26(1):43-50. PubMed ID: 1616496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antioxidant defence, renal toxicity markers and inflammatory cascade in disease progression of acute pyelonephritis in experimental rat model.
    Vysakh A; Raji NR; Suma D; Jayesh K; Jyothis M; Latha MS
    Microb Pathog; 2017 Aug; 109():189-194. PubMed ID: 28578087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental pyelonephritis. VI. Relation between temporary ischemia of the kidney and hematogenic coli bacillus infection in rabbits].
    PRAT V; BENESOVA D; CERVINKA F
    Cas Lek Cesk; 1962 Mar; 101():361-6. PubMed ID: 14488509
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytokine and lymphocyte activation during experimental acute pyelonephritis.
    Roberts JA; Kaack MB; Martin LN
    Urol Res; 1995; 23(1):33-8. PubMed ID: 7618233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of immunization with Escherichia coli J5 on the course of experimental pyelonephritis in rats].
    Straube E; Naumann G; Broschewitz U
    Z Urol Nephrol; 1988 Apr; 81(4):247-55. PubMed ID: 3041706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum resistance of Escherichia coli in chronic pyelonephritis. 1. Serum resistance in the human serum pool].
    Falkenhagen U; Handschuck I; Ulisko IN; Ratiner YuA ; Nimmich W; Zingler G; Naumann G
    Z Urol Nephrol; 1984 Jul; 77(7):391-400. PubMed ID: 6385542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic pyelonephritis: modulation of host defenses by cyclosporin A.
    Findon G; Miller TE
    J Lab Clin Med; 1989 Aug; 114(2):157-64. PubMed ID: 2666534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.